4.7 Article

Preconceptional genetic carrier testing and the commercial offer directly-to-consumers

Journal

HUMAN REPRODUCTION
Volume 26, Issue 5, Pages 972-977

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/humrep/der042

Keywords

preconception care; carrier testing; direct-to-consumer

Funding

  1. Research Fund Flanders (FWO)
  2. European Commission
  3. Centre for Medical Systems Biology
  4. Centre for Society and Genomics
  5. Community Genetics
  6. Clinical Genetics & EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam

Ask authors/readers for more resources

Recently, a number of commercial companies are offering preconceptional carrier tests directly-to-consumers. This offer raises a number of concerns and issues above and beyond those encountered with preconceptional tests offered within the traditional health care setting. In order to bring some of these issues to light and to initiate dialogue on this topic, this article discusses the following issues: the current offer of preconceptional carrier tests (until the end of 2010) through online commercial companies; the implications for the informed consent procedure and the need for good information; the need for medical supervision and follow-up; and the appropriate use of existing resources. The article concludes with some reflections about the potential sustainability of the offer of preconceptional carrier tests directly-to-consumers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available